(Q24242538)

30 October 2023

3

Giovanni FM Strippoli

author given names

G F

author last names

Strippoli

1 reference

30 October 2023

2

Kushma Nand

K

Nand

1 reference

18253993

Cochrane Database of Systematic Reviews

30 October 2023

language of work or name

1 reference

23 January 2008

0 references

published in

0 references

cites work

Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Mycophenolate mofetil treatment for primary glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Treatment of nephrotic hyperlipoproteinemia with gemfibrozil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Effect of a high protein diet in patients with the nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Use of cyclosporine A in the treatment of refractory nephrotic syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Nephrotic Syndrome Due to Primary Renal Disease in Adults: II. A Controlled Trial of Prednisolone and Azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Treatment of hyperlipidemia in the nephrotic syndrome: the effects of pravastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Non-corticosteroid treatment for nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Recent approaches to the pathogenesis of minimal-change nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Interventions for idiopathic steroid-resistant nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Corticosteroid therapy for nephrotic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

The racial prevalence of glomerular lesions in nephrotic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Adult-onset minimal change nephrotic syndrome: a long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001537.PUB4

Treatment of proteinuric patients with a vegetarian soy diet and fish oil.

21 January 2018

1 reference

12 December 2020

Adult minimal change nephropathy: experience of the collaborative study of glomerular disease.

1 reference

12 December 2020

Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome

1 reference

12 December 2020

Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults

1 reference

12 December 2020

Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome

1 reference

12 December 2020

Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology

1 reference

12 December 2020

Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis

1 reference

12 December 2020

Long-term cyclosporin A treatment in adults with refractory nephrotic syndrome

1 reference

12 December 2020

Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome

1 reference

12 December 2020

Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997

1 reference

12 December 2020

Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome

1 reference

12 December 2020

Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome.

1 reference

12 December 2020

Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome

1 reference

12 December 2020

Alternate-day steroid therapy in adult nephrotics

1 reference

12 December 2020

Successful mycophenolate mofetil treatment of glomerular disease

1 reference

12 December 2020

Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome

1 reference

12 December 2020

Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria

1 reference

12 December 2020

Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome

1 reference

12 December 2020

Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome

1 reference

12 December 2020

[A controlled clinical trial of Consupren versus cyclophosphamide in chronic glomerulonephritis]

1 reference

12 December 2020

Controlled trial of prednisone in adult patients with the nephrotic syndrome

1 reference

12 December 2020

Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.

1 reference

12 December 2020

Cyclosporine in the treatment of idiopathic nephrosis

1 reference

12 December 2020

Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome

1 reference

12 December 2020

The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.

1 reference

12 December 2020

Cyclosporine for nephrotic syndrome--isn't it time for a collaborative trial?

1 reference

12 December 2020

Long-term outcome of adult-onset minimal-change nephropathy

1 reference

12 December 2020

Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie

1 reference

12 December 2020

A double-blind trial of "alternate-day" steroid therapy in adult nephrotics--a preliminary report

1 reference

12 December 2020

Long-Term Cyclosporin in Steroid-Dependent Nephrotic Syndrome

1 reference

12 December 2020

The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)

1 reference

12 December 2020

Novel trial for the treatment of steroid dependency in minimal change disease: combined therapy of camostat mesilate and glycyrrhizin

1 reference

12 December 2020

A randomized trial of cyclosporine with low-dose prednisone compared with high-dose prednisone in nephrotic syndrome

1 reference

12 December 2020

Idiopathic nephrotic syndrome: prevention of early relapse

1 reference

12 December 2020

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

1 reference

12 December 2020

Evaluation of prednisolone pulse therapy in steroid-resistant nephrotic syndrome. A multicenter collaborative study.

1 reference

12 December 2020

Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group

1 reference

12 December 2020

Treatment with cyclosporine of adult idiopathic nephrotic syndrome resistant to corticosteroids and other immunosuppressants

1 reference

12 December 2020

Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patients with nephrotic syndrome

1 reference

12 December 2020

Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome

1 reference

12 December 2020

164 children with nephrosis

1 reference

12 December 2020

Management of minimal lesion glomerulonephritis: evidence-based recommendations

1 reference

12 December 2020

Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease

1 reference

12 December 2020

10.1002/14651858.CD001537.PUB4

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1387792

Fatcat ID

release_kdhq22vzk5fwpkw7ljv66a5vce

0 references

OpenCitations bibliographic resource ID

1387792

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1387792